跳至主要内容
临床试验/PACTR201110000321348
PACTR201110000321348已完成未知

INTRAVENOUS ARTESUNATE PLUS ACT Vs INTRAVENOUS QUININE PLUS ACT FOR SEVERE MALARIA TREATMENT IN UGANDAN PATIENTS

INFECTIOUS DISEASES INSTITUTE LTD0 个研究点目标入组 404 人开始时间: 2011年10月4日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
404

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
6 Month(s) 至 60 Year(s)(—)
性别
All

入选标准

  • 1) Age 6 months and above
  • 2) With a positive blood smear for P. falciparum asexual parasitaemia with no other cause of the symptoms
  • 3) Who meet the WHO clinical or laboratory criteria for severe malaria requiring parenteral therapy
  • 3) Whose parents/caretakers provide written informed consent and are willing to participate in 42 day follow up

排除标准

  • 1) Administration of any additional antimalarial drugs that are not study drugs within 72 hours before study enrolment and during the course of the study.
  • 2) Emergence of any non-malarial febrile illness which may interfere with the classification of malaria treatment outcome
  • 3) Movement away from the study area interfering with follow-up assessment
  • 4) Patients with contraindications to taking the study drugs
  • 5) Withdrawal of consent

研究者

发起方
INFECTIOUS DISEASES INSTITUTE LTD

相似试验